Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sevoflurane vs Propofol for Botulinum Toxin Injection in CP Children
NCT05505123Withdrawn
- Sponsor
- Yeungnam University College of Medicine
- Start
- Aug 2022
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial in cerebral palsy (CP) comparing Sevoflurane Arm with Propofol Arm (2 arms). Primary endpoint: Emergence time up to 1 hour. Planned start Aug 2022; status: withdrawn.
02
Drugs
sevofluranepropofol
03
Conditions
cerebral palsy (CP)
Beyond the preview
Go deeper on NCT05505123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05505123.